1.

Slovenian renal replacement therapy registry : 2007 and 2008 annual report

This national analysis shows national epidemiological data on renal replacement therapy in Slovenia. Available at: http://www.nephro-slovenia.si/register2007-8.pdf

COBISS.SI-ID: 27565273

2.

Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation

Basiliximab or daclizumab combined with triple therapy is an efficient and safe immunosuppression strategy, demonstrated with low incidence of acute rejections, excellent graft function, high survival rates, and acceptable adverse event profile after deceased donor renal transplantation.

COBISS.SI-ID: 516160025

3.

Non-matured arteriovenous fistulae for haemodialysis: diagnosis, endovascular and surgical treatment.

A great majority of non-matured fistulae can be successfully salvaged using percutaneous techniques. In addition to endovascular techniques, surgical intervention can also be an option. This paper reviews the process of fistula maturation and presents information regarding how to obtain a mature fistula.

COBISS.SI-ID: 26919897

4.

Left ventricular echocardiographic abnormalities 1 year after kidney transplantation are associated with graft function and cardiovascular events.

Decreased graft function was associated with greater left ventricular mass. Greater left ventricular mass and presence of left ventricular hypertrophy were associated with an increased risk for future cardiovascular events.

COBISS.SI-ID: 27755225

5.

Pretransplant soluble CD30 serum concentration does not affect kidney graft outcomes 3 years after transplantation

The results of this study show that pre-transplant sCD30 does not predict renal graft function and survival three years after kidney transplantation.

COBISS.SI-ID: 27755481